DK
Deepak Kumar Agarwal
About Deepak Kumar Agarwal
Data last updated:
Deepak Kumar Agarwal is a Director at Sankur Pharmaceuticals Private Limited (since 2016), Director at Meek Pharma Private Limited (since 2005) and Director at Nilanga Biomedica Private Limited (since 2024). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹19.94 Cr; the largest is Sankur Pharmaceuticals Private Limited at ₹12.67 Cr (FY 2024). Earlier, Deepak Kumar Agarwal was a Director at Globin Pharmaceuticals Private Limited (2006–2021) and Managing Director at Nilanga Pharmaceuticals Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sankur Pharmaceuticals Private Limited U74120UP2016PTC076748 | Director | 23 Feb 2016 | 2016 | ₹12.67 Cr (FY 2024) | Active |
 Meek Pharma Private Limited U24230UR2005PTC000876 | Director | 22 Aug 2005 | 2005 | ₹7.27 Cr (FY 2025) | Active |
 Nilanga Biomedica Private Limited U46497UP2024PTC205159 | Director | 24 Jun 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Globin Pharmaceuticals Private Limited U24239HR2000PTC034453 | Director | 01 Oct 2006 | 2000 | ₹18.48 Cr (FY 2024) | Active |
| Nilanga Pharmaceuticals Private Limited U24290UP2019PTC115776 | Managing Director | 11 Apr 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Deepak Kumar Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chirayush Singhal | 07439209 | Sankur Pharmaceuticals Private Limited | Director |
| Akash Sharma | 10859681 | Meek Pharma Private Limited | Director |
| Ankur Agarwal | 00548259 | Meek Pharma Private Limited | Director |
| Anshul Agarwal | 06885646 | Meek Pharma Private Limited | Director |
| Ashok Kumar Agarwal | 03169551 | Meek Pharma Private Limited | Director |
| Sachin Kumar Agrawal | 10730615 | Meek Pharma Private Limited | Director |
| Dewang Agarwal | 10988273 | Nilanga Biomedica Private Limited | Director |
| Diwakar Singhal | 10988269 | Nilanga Biomedica Private Limited | Director |
| Shailza Agarwal | 08419086 | Nilanga Biomedica Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Kumar Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Kumar Agarwal
Deepak Kumar Agarwal currently holds 3 directorships: Sankur Pharmaceuticals Private Limited (Director, since 23 Feb 2016, revenue ₹12.67 Cr (FY 2024)); Meek Pharma Private Limited (Director, since 22 Aug 2005, revenue ₹7.27 Cr (FY 2025)); Nilanga Biomedica Private Limited (Director, since 24 Jun 2024).
Deepak Kumar Agarwal was first appointed on 22 Aug 2005 as Director at Meek Pharma Private Limited. The most recent appointment on record is 24 Jun 2024 at Nilanga Biomedica Private Limited.
The 2 current companies of Deepak Kumar Agarwal that report revenue have a combined latest revenue of ₹19.94 Cr: Sankur Pharmaceuticals Private Limited ₹12.67 Cr (FY 2024); Meek Pharma Private Limited ₹7.27 Cr (FY 2025).
Deepak Kumar Agarwal held 2 earlier board appointments: Globin Pharmaceuticals Private Limited (Director, 01 Oct 2006 to 18 Mar 2021); Nilanga Pharmaceuticals Private Limited (Managing Director, from 11 Apr 2019).
The current boards of Deepak Kumar Agarwal's companies include Chirayush Singhal (Sankur Pharmaceuticals Private Limited), Akash Sharma (Meek Pharma Private Limited), Ankur Agarwal (Meek Pharma Private Limited), Anshul Agarwal (Meek Pharma Private Limited), Ashok Kumar Agarwal (Meek Pharma Private Limited), Sachin Kumar Agrawal (Meek Pharma Private Limited), among others.